CTRI/2014/04/004545
Completed
未知
To compare efficacy, safety and cost-effectiveness of rupatadine and olopatadine in patients of chronic idiopathic urticaria: a randomized, double-blind, comparative, parallel group study.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- patients with chronic spontaneous urticaria
- Sponsor
- Indira Gandhi Government Medical college
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria
- •1\) Those who were willing to participate in the study and comply with its procedures by signing a written informed consent.
- •2\) Patients from Out\-Patient Department (OPD) of dermatology between age group of 18 to 65 years of either sex.
- •3\) History of urticarial wheal and/or angioedema for at least 3 days a week for 6 consecutive weeks with no obvious cause prior to inclusion in study.
- •4\) Mean total symptom score (24 hour reflective) \>\= 3 at screening. This includes 1\-5 number of wheals (score \>\= 1\); at least a moderate severity of pruritus (score\>\=2\).
- •5\) Patients who were on any antihistamines except rupatidine and olopatadine were also included in the trail only after giving washout period of 7 days, irrespective of doses of the previous drugs.
- •6\) Those who understood and agreed to adhere to the dosing and visit schedules, and agree to assess and record their symptom severity scores, medication times, concomitant medications, and adverse events accurately and consistently in a daily diary.
Exclusion Criteria
- •Exclusion criteria
- •1\) History of asthma or any other disease requiring chronic use of inhaled or systemic corticosteroids.
- •2\) Subjects with acute spontaneous urticaria or all physical and other subtypes of urticaria like aquagenic, cholinergic, contact and exercise induced urticaria
- •3\) Had been unresponsive to antihistamine treatment in the past.
- •4\) History of allergies to study medication or unable to tolerate antihistamines.
- •5\) Use of study drug in the last 7 days prior to baseline and not willing to take washout period.
- •6\) Pregnant female, nursing mothers.
- •7\) Subjects with significant hematopoietic, cardiovascular, hepatic, renal, neurologic, psychiatric or autoimmune disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
To compare two different iron injections for treatment of anaemia in pregnancyCTRI/2017/07/009088All India Institute of Medical Sciences60
Not yet recruiting
Not Applicable
Effectiveness of montelukast plus bilastine vs montelukast plus levocetirizine in allergic rhinitis.Health Condition 1: J309- Allergic rhinitis, unspecifiedCTRI/2024/08/071971Dr Ganesh Dakhale
Recruiting
Not Applicable
A clinical trial to study the effect of two drugs,caffeine & aminophylline in preterm babies with cessation of breathing due to prematurityHealth Condition 1: null- Preterm neonatesCTRI/2012/08/002904Indian Council of Medical Research ICMR225
Not yet recruiting
Phase 4
A clinical trial to study the effects and safety of two drugs, amlodipine and s-amlodipine in patients with mild to moderate blood pressure for 16 weeksCTRI/2024/05/068049Indira Gandhi Government Medical College and Hospital, Nagpur.
Recruiting
Phase 4
A clinical trial to study the effects of two drugs, Lornoxicam and Ibuprofen in moderate to severe menstrual cramping pain due to primary dysmenorrhoeaHealth Condition 1: N944- Primary dysmenorrheaHealth Condition 2: null- primary dysmenorrhoeaCTRI/2011/12/002188Government Medical College Bhavnagar75